Gerhard Bauer

Title(s)Adjunct Professor, Hematology and Oncology
SchoolSchool of Veterinary Medicine
AddressCTSC, Suite 1300
CA 95817
Phone916-703-9300
vCardDownload vCard

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Transplanted human neural stem cells rescue phenotypes in zQ175 Huntington's disease mice and innervate the striatum. Mol Ther. 2023 Dec 06; 31(12):3545-3563. Holley SM, Reidling JC, Cepeda C, Wu J, Lim RG, Lau A, Moore C, Miramontes R, Fury B, Orellana I, Neel M, Coleal-Bergum D, Monuki ES, Bauer G, Meshul CK, Levine MS, Thompson LM. PMID: 37807512; PMCID: PMC10727970.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimalsCells
    2. Challenges of translating a cell therapy to GMP. Int Rev Neurobiol. 2022; 166:207-234. Bauer G, Fury B. PMID: 36424093.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    3. Target receptor identification and subsequent treatment of resected brain tumors with encapsulated and engineered allogeneic stem cells. Nat Commun. 2022 05 19; 13(1):2810. Bhere D, Choi SH, van de Donk P, Hope D, Gortzak K, Kunnummal A, Khalsa J, Revai Lechtich E, Reinshagen C, Leon V, Nissar N, Bi WL, Feng C, Li H, Zhang YS, Liang SH, Vasdev N, Essayed W, Quevedo PV, Golby A, Banouni N, Palagina A, Abdi R, Fury B, Smirnakis S, Lowe A, Reeve B, Hiller A, Chiocca EA, Prestwich G, Wakimoto H, Bauer G, Shah K. PMID: 35589724; PMCID: PMC9120173.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansAnimalsCells
    4. Scalable Manufacturing of CAR T cells for Cancer Immunotherapy. Blood Cancer Discov. 2021 Sep; 2(5):408-422. Abou-El-Enein M, Elsallab M, Feldman SA, Fesnak AD, Heslop HE, Marks P, Till BG, Bauer G, Savoldo B. PMID: 34568831; PMCID: PMC8462122.
      View in: PubMed   Mentions: 53     Fields:    Translation:HumansCells
    5. Evidence generation and reproducibility in cell and gene therapy research: A call to action. Mol Ther Methods Clin Dev. 2021 Sep 10; 22:11-14. Abou-El-Enein M, Angelis A, Appelbaum FR, Andrews NC, Bates SE, Bierman AS, Brenner MK, Cavazzana M, Caligiuri MA, Clevers H, Cooke E, Daley GQ, Dzau VJ, Ellis LM, Fineberg HV, Goldstein LSB, Gottschalk S, Hamburg MA, Ingber DE, Kohn DB, Krainer AR, Maus MV, Marks P, Mummery CL, Pettigrew RI, Rutter JL, Teichmann SA, Terzic A, Urnov FD, Williams DA, Wolchok JD, Lawler M, Turtle CJ, Bauer G, Ioannidis JPA. PMID: 34377737; PMCID: PMC8322039.
      View in: PubMed   Mentions: 6  
    6. Safety, tolerability, and pharmacokinetics of allopregnanolone as a regenerative therapeutic for Alzheimer's disease: A single and multiple ascending dose phase 1b/2a clinical trial. Alzheimers Dement (N Y). 2020; 6(1):e12107. Hernandez GD, Solinsky CM, Mack WJ, Kono N, Rodgers KE, Wu CY, Mollo AR, Lopez CM, Pawluczyk S, Bauer G, Matthews D, Shi Y, Law M, Rogawski MA, Schneider LS, Brinton RD. PMID: 33344752; PMCID: PMC7744018.
      View in: PubMed   Mentions: 10  
    7. Primed mesenchymal stem cells package exosomes with metabolites associated with immunomodulation. Biochem Biophys Res Commun. 2019 05 14; 512(4):729-735. Showalter MR, Wancewicz B, Fiehn O, Archard JA, Clayton S, Wagner J, Deng P, Halmai J, Fink KD, Bauer G, Fury B, Perotti NH, Apperson M, Butters J, Belafsky P, Farwell G, Kuhn M, Nolta JA, Anderson JD. PMID: 30926165; PMCID: PMC6682414.
      View in: PubMed   Mentions: 45     Fields:    Translation:HumansCells
    8. Exosomes Derived from Human Primed Mesenchymal Stem Cells Induce Mitosis and Potentiate Growth Factor Secretion. Stem Cells Dev. 2019 03 15; 28(6):398-409. Yuan O, Lin C, Wagner J, Archard JA, Deng P, Halmai J, Bauer G, Fink KD, Fury B, Perotti NH, Walker JE, Pollock K, Apperson M, Butters J, Belafsky P, Farwell DG, Kuhn M, Nolta J, Anderson JD. PMID: 30638129; PMCID: PMC6441283.
      View in: PubMed   Mentions: 33     Fields:    Translation:HumansCells
    9. Mesenchymal stem/stromal cells genetically engineered to produce vascular endothelial growth factor for revascularization in wound healing and ischemic conditions. Transfusion. 2019 02; 59(S1):893-897. Fierro FA, Magner N, Beegle J, Dahlenburg H, Logan White J, Zhou P, Pepper K, Fury B, Coleal-Bergum DP, Bauer G, Gruenloh W, Annett G, Pifer C, Nolta JA. PMID: 30383901; PMCID: PMC6785013.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansAnimalsCells
    10. Concise Review: A Comprehensive Analysis of Reported Adverse Events in Patients Receiving Unproven Stem Cell-Based Interventions. Stem Cells Transl Med. 2018 09; 7(9):676-685. Bauer G, Elsallab M, Abou-El-Enein M. PMID: 30063299; PMCID: PMC6127222.
      View in: PubMed   Mentions: 58     Fields:    Translation:HumansCells
    11. SV-BR-1-GM, a Clinically Effective GM-CSF-Secreting Breast Cancer Cell Line, Expresses an Immune Signature and Directly Activates CD4+ T Lymphocytes. Front Immunol. 2018; 9:776. Lacher MD, Bauer G, Fury B, Graeve S, Fledderman EL, Petrie TD, Coleal-Bergum DP, Hackett T, Perotti NH, Kong YY, Kwok WW, Wagner JP, Wiseman CL, Williams WV. PMID: 29867922; PMCID: PMC5962696.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCells
    12. Therapeutic effects of stem cells in rodent models of Huntington's disease: Review and electrophysiological findings. CNS Neurosci Ther. 2018 04; 24(4):329-342. Holley SM, Kamdjou T, Reidling JC, Fury B, Coleal-Bergum D, Bauer G, Thompson LM, Levine MS, Cepeda C. PMID: 29512295; PMCID: PMC6489814.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansAnimals
    13. Human Neural Stem Cell Transplantation Rescues Functional Deficits in R6/2 and Q140 Huntington's Disease Mice. Stem Cell Reports. 2018 01 09; 10(1):58-72. Reidling JC, Relaño-Ginés A, Holley SM, Ochaba J, Moore C, Fury B, Lau A, Tran AH, Yeung S, Salamati D, Zhu C, Hatami A, Cepeda C, Barry JA, Kamdjou T, King A, Coleal-Bergum D, Franich NR, LaFerla FM, Steffan JS, Blurton-Jones M, Meshul CK, Bauer G, Levine MS, Chesselet MF, Thompson LM. PMID: 29233555; PMCID: PMC5768890.
      View in: PubMed   Mentions: 41     Fields:    Translation:HumansAnimalsCells
    14. Human Genome Editing in the Clinic: New Challenges in Regulatory Benefit-Risk Assessment. Cell Stem Cell. 2017 10 05; 21(4):427-430. Abou-El-Enein M, Cathomen T, Ivics Z, June CH, Renner M, Schneider CK, Bauer G. PMID: 28985524.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    15. The path to successful commercialization of cell and gene therapies: empowering patient advocates. Cytotherapy. 2017 02; 19(2):293-298. Bauer G, Abou-El-Enein M, Kent A, Poole B, Forte M. PMID: 27956199.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    16. Mesenchymal stem cell-based therapy for ischemic stroke. Chinese Neurosurgical Journal. 2016 Dec 1; 2(1):36. Anderson AJ, Pham PM, Contreras CZ, Hoon HM, Fink FK, Johansson JH, Rossignol RJ, Dunbar DG, Showalter SM, Fiehn FO, Bramlett BC, Bardini BR, Bauer BG, Fury FB, Hendrix HK, Chedin CF, EL-Andaloussi ES, Hwang HB, Mulligan MM, Lehtiö LJ, Nolta NJ. .
      View in: Publisher Site   Mentions:
    17. Advances in bone marrow stem cell therapy for retinal dysfunction. Prog Retin Eye Res. 2017 01; 56:148-165. Park SS, Moisseiev E, Bauer G, Anderson JD, Grant MB, Zam A, Zawadzki RJ, Werner JS, Nolta JA. PMID: 27784628; PMCID: PMC5237620.
      View in: PubMed   Mentions: 63     Fields:    Translation:HumansAnimalsCells
    18. Putting a price tag on novel autologous cellular therapies. Cytotherapy. 2016 08; 18(8):1056-1061. Abou-El-Enein M, Bauer G, Medcalf N, Volk HD, Reinke P. PMID: 27288308.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCells
    19. Comprehensive Proteomic Analysis of Mesenchymal Stem Cell Exosomes Reveals Modulation of Angiogenesis via Nuclear Factor-KappaB Signaling. Stem Cells. 2016 Mar; 34(3):601-13. Anderson JD, Johansson HJ, Graham CS, Vesterlund M, Pham MT, Bramlett CS, Montgomery EN, Mellema MS, Bardini RL, Contreras Z, Hoon M, Bauer G, Fink KD, Fury B, Hendrix KJ, Chedin F, El-Andaloussi S, Hwang B, Mulligan MS, Lehtiö J, Nolta JA. PMID: 26782178; PMCID: PMC5785927.
      View in: PubMed   Mentions: 261     Fields:    Translation:HumansCells
    20. Human Mesenchymal Stem Cells Genetically Engineered to Overexpress Brain-derived Neurotrophic Factor Improve Outcomes in Huntington's Disease Mouse Models. Mol Ther. 2016 05; 24(5):965-77. Pollock K, Dahlenburg H, Nelson H, Fink KD, Cary W, Hendrix K, Annett G, Torrest A, Deng P, Gutierrez J, Nacey C, Pepper K, Kalomoiris S, D Anderson J, McGee J, Gruenloh W, Fury B, Bauer G, Duffy A, Tempkin T, Wheelock V, Nolta JA. PMID: 26765769; PMCID: PMC4881765.
      View in: PubMed   Mentions: 87     Fields:    
    21. Gene therapy: a possible future standard for HIV care. Trends Biotechnol. 2015 Jul; 33(7):374-6. Abou-El-Enein M, Bauer G, Reinke P. PMID: 26088914.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansPHPublic Health
    22. Correction: Allopregnanolone Preclinical Acute Pharmacokinetic and Pharmacodynamic Studies to Predict Tolerability and Efficacy for Alzheimer's Disease. PLoS One. 2015; 10(6):e0132210. PLOS ONE Staff. PMID: 26121244; PMCID: PMC4488315.
      View in: PubMed   Mentions:    Fields:    Translation:Animals
    23. Large-scale production of lentiviral vector in a closed system hollow fiber bioreactor. Mol Ther Methods Clin Dev. 2015; 2:15020. Sheu J, Beltzer J, Fury B, Wilczek K, Tobin S, Falconer D, Nolta J, Bauer G. PMID: 26151065; PMCID: PMC4470365.
      View in: PubMed   Mentions: 15  
    24. Efficient Generation of Induced Pluripotent Stem and Neural Progenitor Cells From Acutely Harvested Dura Mater Obtained During Ventriculoperitoneal Shunt Surgery. World Neurosurg. 2015 Nov; 84(5):1256-66.e1. Cary WA, Hori CN, Pham MT, Nacey CA, McGee JL, Hamou M, Berman RF, Bauer G, Nolta JA, Waldau B. PMID: 26074438; PMCID: PMC7602677.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansAnimalsCells
    25. Allopregnanolone preclinical acute pharmacokinetic and pharmacodynamic studies to predict tolerability and efficacy for Alzheimer's disease. PLoS One. 2015; 10(6):e0128313. Irwin RW, Solinsky CM, Loya CM, Salituro FG, Rodgers KE, Bauer G, Rogawski MA, Brinton RD. PMID: 26039057; PMCID: PMC4454520.
      View in: PubMed   Mentions: 25     Fields:    Translation:HumansAnimalsCells
    26. Safety and efficacy of a tCD25 preselective combination anti-HIV lentiviral vector in human hematopoietic stem and progenitor cells. Stem Cells. 2015 Mar; 33(3):870-9. Barclay SL, Yang Y, Zhang S, Fong R, Barraza A, Nolta JA, Torbett BE, Abedi M, Bauer G, Anderson JS. PMID: 25524029.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansAnimalsCells
    27. Intravitreal autologous bone marrow CD34+ cell therapy for ischemic and degenerative retinal disorders: preliminary phase 1 clinical trial findings. Invest Ophthalmol Vis Sci. 2014 Dec 09; 56(1):81-9. Park SS, Bauer G, Abedi M, Pontow S, Panorgias A, Jonnal R, Zawadzki RJ, Werner JS, Nolta J. PMID: 25491299; PMCID: PMC4288143.
      View in: PubMed   Mentions: 74     Fields:    Translation:HumansCellsCTClinical Trials
    28. The business case for cell and gene therapies. Nat Biotechnol. 2014 Dec; 32(12):1192-3. Abou-El-Enein M, Bauer G, Reinke P. PMID: 25489833.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    29. Human COL7A1-corrected induced pluripotent stem cells for the treatment of recessive dystrophic epidermolysis bullosa. Sci Transl Med. 2014 Nov 26; 6(264):264ra163. Sebastiano V, Zhen HH, Haddad B, Derafshi BH, Bashkirova E, Melo SP, Wang P, Leung TL, Siprashvili Z, Tichy A, Li J, Ameen M, Hawkins J, Lee S, Li L, Schwertschkow A, Bauer G, Lisowski L, Kay MA, Kim SK, Lane AT, Wernig M, Oro AE. PMID: 25429056; PMCID: PMC4428910.
      View in: PubMed   Mentions: 90     Fields:    Translation:HumansAnimalsCells
    30. A roadmap toward clinical translation of genetically-modified stem cells for treatment of HIV. Trends Mol Med. 2014 Nov; 20(11):632-42. Abou-El-Enein M, Bauer G, Reinke P, Renner M, Schneider CK. PMID: 25262540.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansAnimalsCells
    31. Cellular manufacturing for clinical applications. Dev Ophthalmol. 2014; 53:178-88. Sheu J, Klassen H, Bauer G. PMID: 24732771.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    32. Stem cell transplantation in the context of HIV--how can we cure HIV infection? Expert Rev Clin Immunol. 2014 Jan; 10(1):107-16. Bauer G, Anderson JS. PMID: 24308835.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimalsCells
    33. HIV-1 vaccine antibody induction against a variable region of HIV-1: a possible link to protective immunity? Immunotherapy. 2013 May; 5(5):453-5. Bauer G. PMID: 23638741.
      View in: PubMed   Mentions:    Fields:    
    34. Good Manufacturing Practices (GMP) manufacturing of advanced therapy medicinal products: a novel tailored model for optimizing performance and estimating costs. Cytotherapy. 2013 Mar; 15(3):362-83. Abou-El-Enein M, Römhild A, Kaiser D, Beier C, Bauer G, Volk HD, Reinke P. PMID: 23579061.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    35. CD25 preselective anti-HIV vectors for improved HIV gene therapy. Hum Gene Ther Methods. 2012 Dec; 23(6):366-75. Kalomoiris S, Lawson J, Chen RX, Bauer G, Nolta JA, Anderson JS. PMID: 23216020; PMCID: PMC4015076.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    36. Mesenchymal stem cells for trinucleotide repeat disorders. Methods Mol Biol. 2013; 1010:79-91. Annett G, Bauer G, Nolta JA. PMID: 23754220; PMCID: PMC3815662.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansAnimalsCells
    37. Fighting HIV with stem cell therapy: one step closer to human trials? Expert Rev Anti Infect Ther. 2012 Oct; 10(10):1071-3. Anderson JS, Bauer G. PMID: 23199392.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    38. Gene therapy for adenosine deaminase-deficient severe combined immune deficiency: clinical comparison of retroviral vectors and treatment plans. Blood. 2012 Nov 01; 120(18):3635-46. Candotti F, Shaw KL, Muul L, Carbonaro D, Sokolic R, Choi C, Schurman SH, Garabedian E, Kesserwan C, Jagadeesh GJ, Fu PY, Gschweng E, Cooper A, Tisdale JF, Weinberg KI, Crooks GM, Kapoor N, Shah A, Abdel-Azim H, Yu XJ, Smogorzewska M, Wayne AS, Rosenblatt HM, Davis CM, Hanson C, Rishi RG, Wang X, Gjertson D, Yang OO, Balamurugan A, Bauer G, Ireland JA, Engel BC, Podsakoff GM, Hershfield MS, Blaese RM, Parkman R, Kohn DB. PMID: 22968453; PMCID: PMC3488882.
      View in: PubMed   Mentions: 109     Fields:    Translation:HumansCellsCTClinical Trials
    39. Generation of an HIV-1-resistant immune system with CD34(+) hematopoietic stem cells transduced with a triple-combination anti-HIV lentiviral vector. J Virol. 2012 May; 86(10):5719-29. Walker JE, Chen RX, McGee J, Nacey C, Pollard RB, Abedi M, Bauer G, Nolta JA, Anderson JS. PMID: 22398281; PMCID: PMC3347262.
      View in: PubMed   Mentions: 45     Fields:    Translation:HumansAnimalsCells
    40. A roadmap for academic health centers to establish good laboratory practice-compliant infrastructure. Acad Med. 2012 Mar; 87(3):279-84. Adamo JE, Bauer G, Berro M, Burnett BK, Hartman KA, Masiello LM, Moorman-White D, Rubinstein EP, Schuff KG. PMID: 22373618; PMCID: PMC3292761.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansAnimals
    41. Long-term effects of intravitreal injection of GMP-grade bone-marrow-derived CD34+ cells in NOD-SCID mice with acute ischemia-reperfusion injury. Invest Ophthalmol Vis Sci. 2012 Feb; 53(2):986-94. Park SS, Caballero S, Bauer G, Shibata B, Roth A, Fitzgerald PG, Forward KI, Zhou P, McGee J, Telander DG, Grant MB, Nolta JA. PMID: 22247454; PMCID: PMC3317435.
      View in: PubMed   Mentions: 30     Fields:    Translation:HumansAnimalsCells
    42. Concise review: Induced pluripotent stem cell-derived mesenchymal stem cells: progress toward safe clinical products. Stem Cells. 2012 Jan; 30(1):42-7. Jung Y, Bauer G, Nolta JA. PMID: 21898694; PMCID: PMC3784250.
      View in: PubMed   Mentions: 128     Fields:    Translation:HumansAnimalsCells
    43. Genetically engineered mesenchymal stem cells as a proposed therapeutic for Huntington's disease. Mol Neurobiol. 2012 Feb; 45(1):87-98. Olson SD, Pollock K, Kambal A, Cary W, Mitchell GM, Tempkin J, Stewart H, McGee J, Bauer G, Kim HS, Tempkin T, Wheelock V, Annett G, Dunbar G, Nolta JA. PMID: 22161544; PMCID: PMC3259334.
      View in: PubMed   Mentions: 37     Fields:    Translation:HumansAnimalsCells
    44. Generation of HIV-1 resistant and functional macrophages from hematopoietic stem cell-derived induced pluripotent stem cells. Mol Ther. 2011 Mar; 19(3):584-93. Kambal A, Mitchell G, Cary W, Gruenloh W, Jung Y, Kalomoiris S, Nacey C, McGee J, Lindsey M, Fury B, Bauer G, Nolta JA, Anderson JS. PMID: 21119622; PMCID: PMC3048185.
      View in: PubMed   Mentions: 34     Fields:    Translation:HumansCells
    45. Mesenchymal stem cells for the treatment of neurodegenerative disease. Regen Med. 2010 Nov; 5(6):933-46. Joyce N, Annett G, Wirthlin L, Olson S, Bauer G, Nolta JA. PMID: 21082892; PMCID: PMC3017479.
      View in: PubMed   Mentions: 207     Fields:    Translation:HumansAnimalsCells
    46. Mesenchymal stem cells for the sustained in vivo delivery of bioactive factors. Adv Drug Deliv Rev. 2010 Sep 30; 62(12):1167-74. Meyerrose T, Olson S, Pontow S, Kalomoiris S, Jung Y, Annett G, Bauer G, Nolta JA. PMID: 20920540; PMCID: PMC3815452.
      View in: PubMed   Mentions: 65     Fields:    Translation:HumansCells
    47. Specific transduction of HIV-susceptible cells for CCR5 knockdown and resistance to HIV infection: a novel method for targeted gene therapy and intracellular immunization. J Acquir Immune Defic Syndr. 2009 Oct 01; 52(2):152-61. Anderson JS, Walker J, Nolta JA, Bauer G. PMID: 19593160; PMCID: PMC3777721.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansAnimalsCells
    48. Anterior cruciate ligament reconstruction with and without computer navigation: a clinical and magnetic resonance imaging evaluation 2 years after surgery. Arthroscopy. 2009 Oct; 25(10):1067-74. Endele D, Jung C, Becker U, Bauer G, Mauch F. PMID: 19801284.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    49. Preintegration HIV-1 inhibition by a combination lentiviral vector containing a chimeric TRIM5 alpha protein, a CCR5 shRNA, and a TAR decoy. Mol Ther. 2009 Dec; 17(12):2103-14. Anderson JS, Javien J, Nolta JA, Bauer G. PMID: 19690520; PMCID: PMC2814390.
      View in: PubMed   Mentions: 32     Fields:    Translation:HumansAnimalsCells
    50. In vivo biosafety model to assess the risk of adverse events from retroviral and lentiviral vectors. Mol Ther. 2008 Jul; 16(7):1308-15. Bauer G, Dao MA, Case SS, Meyerrose T, Wirthlin L, Zhou P, Wang X, Herrbrich P, Arevalo J, Csik S, Skelton DC, Walker J, Pepper K, Kohn DB, Nolta JA. PMID: 18461052; PMCID: PMC3013368.
      View in: PubMed   Mentions: 37     Fields:    Translation:AnimalsCells
    51. Factors affecting human T cell engraftment, trafficking, and associated xenogeneic graft-vs-host disease in NOD/SCID beta2mnull mice. Exp Hematol. 2007 Dec; 35(12):1823-38. Nervi B, Rettig MP, Ritchey JK, Wang HL, Bauer G, Walker J, Bonyhadi ML, Berenson RJ, Prior JL, Piwnica-Worms D, Nolta JA, DiPersio JF. PMID: 17764813; PMCID: PMC2238776.
      View in: PubMed   Mentions: 36     Fields:    Translation:HumansAnimalsCells
    52. Selective survival of peripheral blood lymphocytes in children with HIV-1 following delivery of an anti-HIV gene to bone marrow CD34(+) cells. Mol Ther. 2005 Jul; 12(1):77-86. Podsakoff GM, Engel BC, Carbonaro DA, Choi C, Smogorzewska EM, Bauer G, Selander D, Csik S, Wilson K, Betts MR, Koup RA, Nabel GJ, Bishop K, King S, Schmidt M, von Kalle C, Church JA, Kohn DB. PMID: 15963923.
      View in: PubMed   Mentions: 41     Fields:    Translation:HumansCells
    53. Collection of a mobilized peripheral blood apheresis product from a patient with mucopolysaccharidosis type VII and subsequent CD34+ cell isolation. J Clin Apher. 2004; 19(3):151-3. Hofling AA, Sands MS, Lublin DM, Bauer G, Devine S. PMID: 15493049.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    54. Inhibition of HIV-1 infection by lentiviral vectors expressing Pol III-promoted anti-HIV RNAs. Mol Ther. 2003 Aug; 8(2):196-206. Li MJ, Bauer G, Michienzi A, Yee JK, Lee NS, Kim J, Li S, Castanotto D, Zaia J, Rossi JJ. PMID: 12907142.
      View in: PubMed   Mentions: 66     Fields:    Translation:HumansCells
    55. Inhibition of HIV-1 by lentiviral vector-transduced siRNAs in T lymphocytes differentiated in SCID-hu mice and CD34+ progenitor cell-derived macrophages. Mol Ther. 2003 Jul; 8(1):62-71. Banerjea A, Li MJ, Bauer G, Remling L, Lee NS, Rossi J, Akkina R. PMID: 12842429.
      View in: PubMed   Mentions: 51     Fields:    Translation:HumansAnimalsCells
    56. Expression of small interfering RNAs targeted against HIV-1 rev transcripts in human cells. Nat Biotechnol. 2002 May; 20(5):500-5. Lee NS, Dohjima T, Bauer G, Li H, Li MJ, Ehsani A, Salvaterra P, Rossi J. PMID: 11981565.
      View in: PubMed   Mentions: 281     Fields:    Translation:HumansCells
    57. High-level erythroid-specific gene expression in primary human and murine hematopoietic cells with self-inactivating lentiviral vectors. Blood. 2001 Nov 01; 98(9):2664-72. Moreau-Gaudry F, Xia P, Jiang G, Perelman NP, Bauer G, Ellis J, Surinya KH, Mavilio F, Shen CK, Malik P. PMID: 11675336.
      View in: PubMed   Mentions: 25     Fields:    Translation:HumansAnimalsCells
    58. Gene therapy for pediatric AIDS. Ann N Y Acad Sci. 2000 Nov; 918:318-29. Bauer G, Selander D, Engel B, Carbonaro D, Csik S, Rawlings S, Church J, Kohn DB. PMID: 11131719.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCells
    59. Intrakines--evidence for a trans-cellular mechanism of action. Mol Ther. 2000 Feb; 1(2):165-70. Engel BC, Bauer G, Pepper KA, Bockstoce DC, Yu XJ, Chen SY, Kohn DB. PMID: 10933927.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    60. A clinical trial of retroviral-mediated transfer of a rev-responsive element decoy gene into CD34(+) cells from the bone marrow of human immunodeficiency virus-1-infected children. Blood. 1999 Jul 01; 94(1):368-71. Kohn DB, Bauer G, Rice CR, Rothschild JC, Carbonaro DA, Valdez P, Hao Ql, Zhou C, Bahner I, Kearns K, Brody K, Fox S, Haden E, Wilson K, Salata C, Dolan C, Wetter C, Aguilar-Cordova E, Church J. PMID: 10381536.
      View in: PubMed   Mentions: 59     Fields:    Translation:HumansCellsCTClinical Trials
    61. Stable transduction of quiescent CD34(+)CD38(-) human hematopoietic cells by HIV-1-based lentiviral vectors. Proc Natl Acad Sci U S A. 1999 Mar 16; 96(6):2988-93. Case SS, Price MA, Jordan CT, Yu XJ, Wang L, Bauer G, Haas DL, Xu D, Stripecke R, Naldini L, Kohn DB, Crooks GM. PMID: 10077624; PMCID: PMC15882.
      View in: PubMed   Mentions: 85     Fields:    Translation:HumansCells
    62. Targeted transduction of CD34+ cells by transdominant negative Rev-expressing retrovirus yields partial anti-HIV protection of progeny macrophages. Hum Gene Ther. 1998 May 20; 9(8):1197-207. Davis BR, Saitta FP, Bauer G, Bunnell BA, Morgan RA, Schwartz DH. PMID: 9625259.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    63. Increased gene transfer into human CD34+ progenitor cells using retroviral vectors produced by a canine packaging cell line. Biol Blood Marrow Transplant. 1998; 4(3):119-27. Bauer G, Sauter S, Ibanez C, Rice CR, Valdez P, Jolly D, Kohn DB. PMID: 9923409.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimalsCells
    64. Inhibition of human immunodeficiency virus-1 (HIV-1) replication after transduction of granulocyte colony-stimulating factor-mobilized CD34+ cells from HIV-1-infected donors using retroviral vectors containing anti-HIV-1 genes. Blood. 1997 Apr 01; 89(7):2259-67. Bauer G, Valdez P, Kearns K, Bahner I, Wen SF, Zaia JA, Kohn DB. PMID: 9116267.
      View in: PubMed   Mentions: 21     Fields:    Translation:HumansCells
    65. Suitability of bone marrow from HIV-1-infected donors for retrovirus-mediated gene transfer. Hum Gene Ther. 1997 Feb 10; 8(3):301-11. Kearns K, Bahner I, Bauer G, Wei SF, Valdez P, Wheeler S, Woods L, Miller R, Casciato D, Galpin J, Church J, Kohn DB. PMID: 9048197.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    66. N-acetyl-cysteine and L-2-oxothiazolidine-4-carboxylic acid enhance contact-dependent growth of HIV in resting peripheral blood mononuclear cells (PBMC) in vitro and increase recovery of HIV from human-PBMC SCID mice. AIDS. 1997 Jan; 11(1):33-41. Chen P, Bauer G, Mitchell J, Factor R, Markham R, Schwartz DH. PMID: 9110073.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansAnimalsCells
    67. Phytohemagglutinin-inducible p24 in peripheral blood mononuclear cells as a predictor of human immunodeficiency virus type 1 vertical transmission and infant clinical status. Pediatr Infect Dis J. 1994 Dec; 13(12):1079-82. Farley JJ, Bauer G, Johnson JP, Cole GA. PMID: 7892074.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCellsPHPublic Health
    68. Effect of 2',3'-didehydro-3'-deoxythymidine in an in vitro hollow-fiber pharmacodynamic model system correlates with results of dose-ranging clinical studies. Antimicrob Agents Chemother. 1994 Jun; 38(6):1386-91. Bilello JA, Bauer G, Dudley MN, Cole GA, Drusano GL. PMID: 8092842; PMCID: PMC188215.
      View in: PubMed   Mentions: 38     Fields:    Translation:HumansCells
    69. Preclinical evaluation of antiviral activity and toxicity of Abbott A77003, an inhibitor of the human immunodeficiency virus type 1 protease. Antimicrob Agents Chemother. 1993 Jan; 37(1):115-9. Kort JJ, Bilello JA, Bauer G, Drusano GL. PMID: 8431007; PMCID: PMC187615.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansCells
    70. Antibodies to HIV-1 in urine of children of HIV-1-infected women. Lancet. 1992 Aug 29; 340(8818):559. Bauer G, Johnson J, Lewis G, Gottfried T, Urnovitz H, Cole G. PMID: 1354317.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    71. Inhibition of HIV-1 IIIb replication in AA-2 and MT-2 cells in culture by two ligands of poly (ADP-ribose) polymerase: 6-amino-1,2-benzopyrone and 5-iodo-6-amino-1,2-benzopyrone. Biochem Biophys Res Commun. 1991 Oct 31; 180(2):504-14. Cole GA, Bauer G, Kirsten E, Mendeleyev J, Bauer PI, Buki KG, Hakam A, Kun E. PMID: 1953721.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    Gerhard's Networks
    Concepts (340)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (41)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UC Davis Profiles is managed by the UCSF Clinical and Translational Science Institute (CTSI), part of the Clinical and Translational Science Award program funded by the National Center for Advancing Translational Sciences (Grant Number UL1 TR000004) at the National Institutes of Health (NIH).
    This site is running Profiles RNS version UCSF-v3.1.0-4-g3cb31450 on PROFILES-PWEB04. We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use.

    Copyright © The Regents of the University of California